Literature DB >> 10082578

Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I.

A Musarò1, N Rosenthal.   

Abstract

The molecular mechanisms underlying myogenic induction by insulin-like growth factor I (IGF-I) are distinct from its proliferative effects on myoblasts. To determine the postmitotic role of IGF-I on muscle cell differentiation, we derived L6E9 muscle cell lines carrying a stably transfected rat IGF-I gene under the control of a myosin light chain (MLC) promoter-enhancer cassette. Expression of MLC-IGF-I exclusively in differentiated L6E9 myotubes, which express the embryonic form of myosin heavy chain (MyHC) and no endogenous IGF-I, resulted in pronounced myotube hypertrophy, accompanied by activation of the neonatal MyHC isoform. The hypertrophic myotubes dramatically increased expression of myogenin, muscle creatine kinase, beta-enolase, and IGF binding protein 5 and activated the myocyte enhancer factor 2C gene which is normally silent in this cell line. MLC-IGF-I induction in differentiated L6E9 cells also increased the expression of a transiently transfected LacZ reporter driven by the myogenin promoter, demonstrating activation of the differentiation program at the transcriptional level. Nuclear reorganization, accumulation of skeletal actin protein, and an increased expression of beta1D integrin were also observed. Inhibition of the phosphatidyl inositol (PI) 3-kinase intermediate in IGF-I-mediated signal transduction confirmed that the PI 3-kinase pathway is required only at early stages for IGF-I-mediated hypertrophy and neonatal MyHC induction in these cells. Expression of IGF-I in postmitotic muscle may therefore play an important role in the maturation of the myogenic program.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082578      PMCID: PMC84105          DOI: 10.1128/MCB.19.4.3115

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  Activation of the gene encoding the glycolytic enzyme beta-enolase during early myogenesis precedes an increased expression during fetal muscle development.

Authors:  A Keller; M O Ott; N Lamandé; M Lucas; F Gros; M Buckingham; M Lazar
Journal:  Mech Dev       Date:  1992-07       Impact factor: 1.882

Review 2.  Hormones, growth factors, and myogenic differentiation.

Authors:  J R Florini; D Z Ewton; K A Magri
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

3.  Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.

Authors:  L S Quinn; B Steinmetz; A Maas; L Ong; M Kaleko
Journal:  J Cell Physiol       Date:  1994-06       Impact factor: 6.384

Review 4.  The MyoD family and myogenesis: redundancy, networks, and thresholds.

Authors:  H Weintraub
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

5.  IGF-I is required for normal embryonic growth in mice.

Authors:  L Powell-Braxton; P Hollingshead; C Warburton; M Dowd; S Pitts-Meek; D Dalton; N Gillett; T A Stewart
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer.

Authors:  P Cserjesi; B Lilly; C Hinkley; M Perry; E N Olson
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

8.  Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation.

Authors:  K M Rosen; B M Wentworth; N Rosenthal; L Villa-Komaroff
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

9.  IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation.

Authors:  D Z Ewton; J R Florini
Journal:  J Endocrinol       Date:  1995-03       Impact factor: 4.286

10.  Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice.

Authors:  M E Coleman; F DeMayo; K C Yin; H M Lee; R Geske; C Montgomery; R J Schwartz
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  45 in total

1.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle.

Authors:  Ana M Fernández; Joëlle Dupont; Roger P Farrar; Sukho Lee; Bethel Stannard; Derek Le Roith
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis.

Authors:  Ramon C J Langen; Annemie M W J Schols; Marco C J M Kelders; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

5.  Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.

Authors:  Yi Cao; Zhefeng Zhao; Joanna Gruszczynska-Biegala; Anna Zolkiewska
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

6.  Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle.

Authors:  Anthony M Payne; Zhenlin Zheng; María Laura Messi; Carol E Milligan; Estela González; Osvaldo Delbono
Journal:  J Physiol       Date:  2005-11-17       Impact factor: 5.182

7.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

8.  Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.

Authors:  Elizabeth M Wilson; Jolana Tureckova; Peter Rotwein
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

9.  Action of obestatin in skeletal muscle repair: stem cell expansion, muscle growth, and microenvironment remodeling.

Authors:  Uxía Gurriarán-Rodríguez; Icía Santos-Zas; Jessica González-Sánchez; Daniel Beiroa; Viviana Moresi; Carlos S Mosteiro; Wei Lin; Juan E Viñuela; José Señarís; Tomás García-Caballero; Felipe F Casanueva; Rubén Nogueiras; Rosalía Gallego; Jean-Marc Renaud; Sergio Adamo; Yolanda Pazos; Jesús P Camiña
Journal:  Mol Ther       Date:  2015-03-12       Impact factor: 11.454

10.  Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.

Authors:  Belinda S Cowling; Meagan J McGrath; Mai-Anh Nguyen; Denny L Cottle; Anthony J Kee; Susan Brown; Joachim Schessl; Yaqun Zou; Josephine Joya; Carsten G Bönnemann; Edna C Hardeman; Christina A Mitchell
Journal:  J Cell Biol       Date:  2008-12-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.